Acuta Capital Partners, LLC Karyopharm Therapeutics Inc. Transaction History

Acuta Capital Partners, LLC

  • $122 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$14.38 - $27.72 $8.48 Million - $16.4 Million
-590,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$9.23 - $19.67 $3.25 Million - $6.93 Million
352,500 Added 148.42%
590,000 $11.3 Million
Q3 2019

Nov 14, 2019
BUY
$5.66 - $11.85 $1.34 Million - $2.81 Million
237,500 New
237,500 $2.29 Million

Others Institutions Holding KPTI

# of Institutions
120
Shares Held
72.4M
Call Options Held
476K
Put Options Held
175K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $69.4M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email